Background -Thymic stromal lymphopoietin (TSLP) plays a key role in the development of allergic inflammation. Little is known about possible triggers of equine TSLP expression.
Introduction
Thymic stromal lymphopoietin (TSLP) is an interleukin (IL)-7 like cytokine that plays a central role in TH-2 cell differentiation and development of allergic inflammation. 1 Many cell types produce TSLP including epithelial, mast cells and dendritic cells (DCs), as well as cancer and cancer-associated cells. 2 TSLP-treated DCs induce a strong proliferation of na€ ıve T cells. In addition, under the influence of TSLP, DCs secrete TH2-recruiting chemokines, and induce na€ ıve Tcell differentiation into "inflammatory" TH-2 cells, which in turn produce IL-4, IL-5 and IL-13, and tumor necrosis factor (TNF)-a through the OX40 ligand. 3 Moreover, TSLP does not induce the expression of IL-12 or type I interferons, which would drive the induction of TH-1 differentiation, 4 thus further skewing the immune response towards a TH-2 phenotype. Furthermore, TSLP activates Langerhans cells. 5 In combination with IL-1 and TNF-a, TSLP can act directly on human mast cells that in turn produce IL-5 and IL-13. It also can act on human eosinophils inducing their prolonged survival and secretion of pro-inflammatory molecules. 6 TSLP is highly expressed in lesional keratinocytes of humans affected by atopic dermatitis (AD), where it plays a central role in triggering allergic diseases. 4 Keratinocytes are the predominant cell type in the epidermis, forming the physical barrier to the external environment. 7 Besides this role, keratinocytes also produce several cytokines and chemokines that ultimately shape the immune response. For example, in response to external stimuli, human keratinocytes produce cytokines such as IL-25, IL-33 and TSLP. 7 The production of TSLP by keratinocytes, together with its functional ability to skew the immune response towards TH-2 subtype, makes TSLP a critical factor linking responses at the interface between the body and the external environment to TH-2 phenotype. 8 Information on the environmental and endogenous triggers of TSLP expression, which is essential to elucidate the underlying mechanisms of allergic diseases, is still limited. Bogiatzi et al. have shown that pro-inflammatory and TH-2 cytokines act synergistically to induce TSLP expression in skin explants from healthy donors. 9 In horses, keratinocytes and TSLP have not been studied extensively and little is known about their possible role in the development of allergic diseases such as insect bite hypersensitivity (IBH). IBH is an IgE-mediated, type I hypersensitivity caused by bites of insects in the genus Culicoides, and clinically is seen as a recurrent dermatitis in horses. 10 Although the possible role of TSLP in IBH development is unknown, one study reported the generation of equine TSLP-specific antibodies and showed that TSLP production was induced in equine primary keratinocytes by stimulation with whole-body extract of Culicoides midges, whose salivary gland proteins are causative allergens of equine IBH. 11 However, keratinocytes from only one healthy horse was used in that study. Another study reported TSLP upregulation in bronchial alveolar lavage cells derived from horses affected by equine asthma (RAO) and in bronchial epithelial cells (BAC) after stimulation with hay dust extract in vitro. 12 Possible endogenous or exogenous triggers of equine TSLP expression in homeostasis or disease state remain to be elucidated.
Based on the demonstration that TSLP is the linking factor between the environmental stimuli and the type of immune response, it is hypothesized herein that the expression of equine TSLP is upregulated in primary equine keratinocytes by Toll-like receptor (TLR) ligands (TLR-L). TLRs are pattern recognition receptors that recognize pathogen-associated molecular patterns (PAMPs) on various microbes and therefore play an essential function in innate immunity. 13 Binding of ligands to TLRs leads to the activation of several signalling pathways, including NF-jB and MAP (mitogen-activated protein) kinases that in turn induce the expression of various genes involved in host defence, such as IL-6 and IL-1, chemokines, major histocompatibility complex (MHC) and co-stimulatory molecules. In one study, equine keratinocytes responded to stimulation with LPS (TLR-4 ligand) and flagellin (TLR-5 ligand) by increased expression of inflammatory cytokine genes, suggesting that equine keratinocytes express functional TLR-4 and TLR-5. 14 The primary aim of this study was to investigate whether equine TSLP is differentially expressed in lesional skin of IBH-affected horses compared to the skin of healthy horses. A further aim was to examine in primary equine keratinocytes the capacity of TLR 1-8-L to induce the expression of TSLP and the pro-inflammatory cytokine IL-6, as a downstream effector molecule of TLR signalling. For comparison, the TLR-L-induced TSLP and IL-6 expression in peripheral blood mononuclear cells were examined. Finally, it was investigated whether allergic inflammation cytokine milieu (IL-4 and TNF-a) induces TSLP expression in keratinocytes from nonallergic horses and acts synergistically with TLR-1/2 and TLR-3-induced TSLP expression.
Methods and materials

Sample collection
This study was approved by the Animal Experimental Committee of the Canton of Berne, Switzerland (nos BE 2/17 and BE 69/18).
Nine skin biopsies from IBH-affected and nine skin samples from control horses were taken from the neck or midline area. Biopsies were collected from slaughtered horses or from IBH-affected horses. Subsequently, the biopsies were bisected and submerged in RNAlater (Thermo Fisher Scientific; Waltham, MA, USA) and stored at -80°C until further processing. Blood for isolation of peripheral blood mononuclear cells (PBMCs) was collected from three nonallergic horses.
Isolation and culture of primary equine keratinocytes
Primary equine keratinocytes were isolated from skin samples obtained from six slaughtered horses with no apparent skin disease. The cells were cultured using a modification of protocols described previously. 11, 15 Briefly, skin samples were incubated at 4°C for 24h with 10 mg/mL Dispase II (Roche; Basel, Switzerland) in Williams E medium (Bioconcept; Allschwil, Switzerland). Subsequently, epidermis was separated from the dermis using sterile forceps and further digested for 20 min in accutase (CELLnTEC; Bern, Switzerland) in order to produce single-cell suspensions. Once acquired, keratinocytes were seeded at 12 x 10 3 cells per cm 2 of cell culture flask and grown in Williams E medium supplemented with 10% fetal bovine serum (Merck; Kenilworth, NJ, USA), 10 ng/mL human epidermal growth factor (Sigma Aldrich; St Louis, MO, USA), 2 mM glutamine, 50 U/mL penicillin, 50 mg/mL streptomycin and amphotericin B (Bioconcept). Cells were grown in 75 cm 2 flasks at a density of 9 x 10 5 cells per flask and grown at 35°C, 5% CO 2 until they reached 90% confluence. Cells from passage three were used for stimulation experiments.
Isolation of peripheral blood mononuclear cells
Blood from three nonallergic horses was collected from the jugular vein using sodium heparin-containing vacutainers (Vacuette, Greiner; St Gallen, Switzerland). Blood was transferred immediately to the laboratory where PBMCs were isolated by density gradient centrifugation over Ficoll-Hypaque in accordance with Hamza et al. 16 
Immunofluorescence
In order to confirm the presence of primary equine keratinocytes in the cultures, cells were grown in chambered cell culture slides (Sarstedt; N€ umbrecht, Germany) until they reached 70% confluence. Subsequently, cells were fixed using 4% paraformaldehyde (Thermo Fisher Scientific) for 20 min at room temperature. Cells then were permeabilized using 0.2% Triton (Biorad; Hercules, CA, USA) and blocked in 10% normal goat serum (AbCam; Cambridge, UK). They were incubated overnight at 4°C with the following primary antibodies: polyclonal rabbit anti-bovine cytokeratin (Agilent; Santa Clara, CA, USA) and mouse monoclonal anti-human vimentin (Agilent) at 4°C. Washing with 0.025% Tween 20 (Sigma Aldrich) and 45 min incubation at room temperature with the corresponding secondary antibodies, Alexa Flour 647-labelled goat anti-rabbit (Jackson ImmunoResearch; West Grove, PA, USA) and Alexa Flour 647-labelled goat-anti mouse (Invitrogen) followed. Nuclei were counterstained with Hoechst (Sigma Aldrich). Cells were imaged using Zeiss AxioImager Z1 (Carl Zeiss AG; Oberkochen, Germany). The staining was carried out for all keratinocyte cultures used in this study.
Stimulation of keratinocytes and PBMCs
Primary equine keratinocytes of passage three were seeded in six well plates at a density of 3 x 10 5 cells per well and grown at 35°C, 5% CO 2 until they reached 90% confluence. For stimulation experiments, cells were cultured in complete Williams E medium. After isolation, equine PBMCs were cultured in 12 well plates at a density of 8 x 10 6 cells per well in RPMI medium.
Primary keratinocytes and PBMCs were cultured in medium only or with various TLR-L (as summarized in Table 1 ) for 4 h and 24 h.
Furthermore, a combination of 50 ng/mL phorbol 12-myristate 13-acetate(PMA) (Sigma Aldrich) and 1 lmol/mL ionomycin (Sigma Aldrich) or 5 lg/mL Concanavalin A (Sigma Aldrich) were used as positive controls. Additionally, a combination of 100 ng/mL recombinant equine TNF-a (R&D Systems; Minneapolis, MN, USA) and 100 ng/mL recombinant equine IL-4 (LubioScience; Z€ urich, Switzerland) was added to primary equine keratinocytes cultured in the presence or absence of Pam3CSK4 and Poly (I:C).
Isolation of RNA and cDNA synthesis
Total RNA was isolated from cultured keratinocytes using ReliaPrep RNA Cell miniprep system (Promega; Madison, WI, USA) according to the manufacturer's instructions. Total RNA was extracted from cultured PBMCs using the RNeasy Mini Kit (Qiagen; Hilden, Germany) according to the manufacturer's instructions. Before RNA extraction with the RNeasy Mini Kit, cell lysates were loaded onto a spin column (QIAshredder; Qiagen) and centrifuged at 16,000g for 2 min. Total RNA from lesional skin of IBH-affected (n = 9) and healthy horses (n = 9) was extracted using the RNeasy Fibrous Tissue Kit (Qiagen). 17 Before RNA extraction, skin samples were lysed using MagNa tissue lyser (Roche) in which samples were homogenized by collision with ceramic beads (Roche) for 45 s at the shaking speed of 6,500, followed by 2 min cooling on ice. Homogenization was repeated for another 30 s at the shaking speed of 6,500 and supernatants were loaded onto a spin column (QIAshredder, Qiagen) and centrifuged at 16,000g for 2 min (Qiagen). For all samples, contaminating genomic DNA was removed by oncolumn DNase treatment, and RNA was quantified spectrophotometrically at 260 nm (NanoDrop 2000c, Thermo Fischer Scientific; Reinach, Switzerland) and samples were stored at -80°C until use.
Reverse transcription (RT) of total RNA was performed using GoScript Reverse Transcription Mix (Promega) to generate complementary DNA (cDNA) that was used as a template for quantitative (q) RT-PCR. The cDNA synthesis reaction consisted of 500 ng RNA and 10 uL GoScript Reverse Transcription Mix, which contained 4 lL nuclease-free water, 4 lL GoScript Reaction Buffer and Random Primer, and 2 lL GoScript Enzyme Mix, in a total reaction volume of 20 lL. RNA samples and the RT mix were incubated at 25°C for 5 min. Reaction continued at 42°C for 1 h and was terminated by heating at 70°C for 15 min. The cDNA samples were stored at -20°C until further processing.
qRT-PCR of primary keratinocytes, PBMCs and skin
Expression of TSLP, IL-6 and the housekeeping gene ubiquitin B (UBB) was quantified using qRT-PCR. TSLP and UBB primer sequences were applied as previously published and IL-6 primers were designed using the PRIMER EXPRESS 3.0.1. program and synthesized by Microsynth (Balgach, Switzerland) (Sequences in Table 2 ). 17 The qRT-PCR mixes consisted of: 1 lL cDNA per reaction, GoTaq Master Mix 2x (Promega), CXR reference dye 100x (Promega, and 100 lM primers. The qRT-PCR reactions were performed in a total volume of 10 lL and carried out in a 7300 Real-Time PCR System (Applied Biosystems; Foster City, CA, USA). The UBB and TSLP qRT-PCR reaction consisted of initial 15 min at 95°C, followed by 45 cycles of denaturation for 15 s at 95°C, annealing for 30 s at 60°C, elongation for 30 s at 72°C, and a melting curve program of 95°C for 15 s, followed by 30 s at 60°C and 15 s at 95°C.
The IL-6 qRT-PCR reactions consisted of an initial 2 min at 50°C and denaturation at 95°C for 10 min, followed by 40 cycles of denaturation for 15 s at 95°C, annealing at 60°C for 1 min, and the same melting curve program as for the UBB and TSLP qRT-PCR reaction. All reactions were performed in triplicate, and no template and RTnegative controls were included in each run. Efficiencies of qRTPCRs were calculated using a standard curve derived from pool of cDNA (Table 2 ). TSLP and IL-6 gene expression in primary equine keratinocytes and PBMCs was quantified using the ΔΔCt method. Expression of TSLP and IL-6 was normalized to the expression of UBB and to the nonstimulated control.
In six of nine skin samples from control horses, and two of nine samples from IBH-affected horses, TSLP expression was below the detection limit of the assay. A Ct = 40 was attributed to these samples to allow their inclusion in the statistical analysis. TSLP expression in skin samples was quantified using the 1/2 ΔCt method, as described in Hamza et al.; 1/2 ΔCt expresses the relative quantity of TSLP mRNA present in the sample compared to the amount of UBB in the sample. 16 
Statistical analyses
For statistical analysis, NCSS software [NCSS 12 Statistical Software (2018) NCSS, LLC; Kaysville, UT, USA, ncss.com/software/ncss] was used. Because the data were not normally distributed, descriptive statistics using median and ranges were used. Comparison of TSLP mRNA expression in lesional IBH skin to its expression in skin from healthy horses was performed using the Wilcoxon-Mann-Whitney U-test, as was comparison of cytokine expression between TLR-ligand stimulated and unstimulated keratinocytes. Bonferroni correction for multiple comparisons (cP) was performed manually (P-value x number of comparisons = cP). On each occasion, P ≤ 0.05 was regarded as significant. In order to compare the effect of addition of inflammatory cytokine milieu on keratinocyte cultures within each culture conditions (i.e. within each TLR-ligand stimulation or without addition of TLR-ligand), a paired Wilcoxon signed rank test was performed.
Results
TSLP expression in lesional skin of IBH-affected horses
The mRNA expression of TSLP was significantly greater (median = 0.0114, range 0.0006-0.0580, P < 0.05) in lesional skin of IBH-affected horses compared to the skin of nonaffected controls (0.0009, 0.0005-0.0203) (Figure 1 ).
Establishment of primary equine keratinocyte cultures
Primary equine keratinocytes were morphologically distinctive in culture as cobble stone-shaped cells with ovoid nucleus and indistinct borders. 15 Morphologically, all of the cultures herein corresponded to the description of keratinocytes. In addition, staining of the primary keratinocyte cultures with anti-cytokeratin confirmed that all of the cultures consisted of keratinocytes (Figure 2a ). Moreover, no staining was observed with the anti-vimentin antibody, indicating that the cultures were not contaminated with fibroblasts, which are common in keratinocyte cultures (Figure 2b ). When anti-vimentin antibody was used on equine fibroblasts as control staining, positive staining was observed, confirming antibody reactivity on equine fibroblasts (Figure 2c,d) . After 24 h stimulation of keratinocytes (Figure 3b ), the effect of some stimuli decreased and there was no significant difference for flagellin and resiquimod compared to unstimulated cells. TSLP was still significantly upregulated after 24 h by PMA-ionomycin, Pam3CSK4, Poly (I:C) and LPS. The strongest upregulation of TSLP after 24 h stimulation was induced by Poly (I:C) (median = 53.13). PMA-ionomycin (12.68) and Pam3CSK4 (4.25) induced a significant upregulation of TSLP as well, but to a lower extent than after 4 h, whereas TSLP expression induced by Poly (I:C) was 10-fold higher after 24 h compared to 4 h stimulation (Figure 3b ). Medians of both TSLP and IL-6 expression values for all stimulation conditions are shown in Table S1 .
TLR ligands and IL-6 gene expression in primary equine keratinocytes and PBMCs
In a similar way to TSLP expression, the expression of the pro-inflammatory cytokine IL-6 was significantly upregulated in primary equine keratinocytes after 4 h stimulation with PMA-ionomycin, Pam3CSK4, Poly (I:C), LPS and flagellin. However, in contrast to TSLP expression, stimulation with resiquimod did not induce a significant IL-6 increased expression. After 4 h stimulation (Figure 3c) , the strongest upregulation of IL-6 in equine keratinocytes was induced with Pam3CSK4 (median = 42.00), followed by LPS (13.27), PMA-ionomycin (7.84) and Poly (I:C) (7.06). After 24 h stimulation (Figure 3b) , similar to TLR-L-induced TSLP expression, the effect of some TLR-L on IL-6 upregulation decreased. A significant upregulation of IL-6 after 24 h was induced only by Poly (I:C) and LPS stimulation. As for TSLP, the strongest IL-6 response was observed after stimulation with Poly (I:C) (median = 54.94) (Figure 3d) .
In comparison to keratinocytes, IL-6 was upregulated in PBMCs after 4 h by PMA-ionomycin, Pam3CSK4, LPS, flagellin and resiquimod, and weakly by Poly (I:C) stimulation ( Figure S1c,d) . Effects of IL-4 and TNFa with Pam3CKS4 and Poly (I:C) on TSLP and IL-6 gene expression in primary equine keratinocytes.
The subtitle was removed from here, which in my opinion makes the part of cytokine milieu less visible. Since this is quite an interesting part, I would be very grateful if we could have a subtitle here. Treatment with recombinant equine IL-4 and TNF-a, which mimics an atopic inflammatory cytokine milieu, significantly upregulated TSLP gene expression after 4 h and 24 h in primary equine keratinocytes. Moreover, the combination of Pam3CKS4 and atopic cytokine milieu had a synergistic effect on upregulation of TSLP gene expression. Although Pam3CSK4 alone already induced a strong upregulation of TSLP, the combination with atopic cytokine milieu further increased TSLP expression. Moreover, although the effect of stimulation with Pam3CSK4 was only strong after 4 h and dampened after 24 h stimulation, the combination with atopic cytokine milieu significantly enhanced TSLP expression even after 24 h (Figure 4a,b) .
The same effect of atopic cytokine milieu was observed in combination with Poly (I:C). The synergistic effect of the milieu and Poly (I:C) on TSLP gene expression was seen both after 4 h and 24 h stimulation, with TSLP gene expression significantly enhanced at both time points, when compared to stimulation with Poly (I:C) only (Figure 4a,b) .
Next, the effect of the atopic cytokine milieu and Pam3CSK4 or Poly (I:C) on IL-6 gene expression was examined. After 4 h stimulation (Figure 4c ), as expected, stimulation with Pam3CSK4 and Poly (I:C) alone induced IL-6 expression. However, by contrast to TLSP expression, addition of IL-4 and TNF-a to the culture medium did not induce any significant upregulation of IL-6 after 4 h stimulation. Moreover, addition of cytokine milieu to Pam3CSK4 did not induce a significant upregulation of IL-6 after 4 h stimulation, either. Combination of Poly (I:C) and atopic cytokine milieu induced a significant upregulation of IL-6 after 4 h stimulation, when compared to stimulation induced by Poly (I:C) only, but the effect was much weaker for IL-6 compared to TSLP expression. Twenty-four hour stimulation with atopic cytokine milieu significantly upregulated IL-6 gene expression. The addition of atopic inflammation cytokine milieu to Pam3CSK4 or Poly (I:C) induced a statistically significant further upregulation of IL-6 ( Figure 4d ).
Discussion
The present study demonstrates that equine TSLP is significantly upregulated in lesional skin from IBH-affected horses when compared to healthy controls, thus indicating a potential role of this cytokine in the pathogenesis of IBH. A study has shown that TSLP protein is highly expressed in lesional skin of AD human patients, with no expression in patients without skin disease, which suggests that TSLP expression patterns are similar in equine and human counterparts. 4 The data herein suggested that TSLP is involved in the pathogenesis of equine IBH, so the possible triggers of TSLP expression were investigated. Being on the interface between body and the environment, keratinocytes are in constant contact with a plethora of bacteria and viruses. Thus, it was hypothesized that TLR-L that correspond to certain bacterial-and viral PAMPs upregulate TSLP expression. First, primary equine keratinocytes cultures were established using modified protocols. 11, 15 Although fibroblast contaminations can be common in keratinocyte cultures, the protocol used herein yielded fibroblast-free cultures, as demonstrated by immunofluorescence staining of cytokeratin and vimentin.
Even though all TLR-L except TLR-L 9, induced a significant TSLP upregulation, the strongest upregulation after 4 h was induced by Pam3CSK4, which is a synthetic triacylated lipoprotein found in both Gram-positive and -negative bacteria, and ligand for TLR 1/2. Interestingly, the strongest TSLP upregulation after 24 h stimulation was observed with Poly (I:C), and this upregulation was much stronger when compared to 4 h upregulation. Poly (I:C) is a synthetic analogue of double-stranded RNA (dsRNA), that can be recognized by TLR-3. Unlike TLR-1/2, À4 and À5, TLR-3 is an intracellular TLR, which may account for the prolonged time needed for the Poly (I:C) to induce TSLP and IL-6 upregulation, in comparison with ligands stimulating TLRs expressed on the cell membrane. 18 In human keratinocytes, TSLP upregulation is induced via TLR-L 2/6, 3 and 5, after 18 h stimulation. [19] [20] [21] [22] Interestingly, Pam3CKS4 did not induce TSLP expression in human keratinocytes. 19 A possible reason for this discrepancy between the effect of Pam3CSK4 on human and equine keratinocytes might be the origin of the reagent. Additionally, 200 ng/mL Pam3CSK4 was used, whereas human keratinocytes were stimulated with 5 lg/mL. 19 When 5 lg/mL Pam3CSK4 was used to stimulate equine keratinocytes, TSLP gene expression was upregulated as compared to nonstimulated cells, but the upregulation was not as strong as with a lower concentration of this TLR-L, suggesting that 5 lg/mL of Pam3CSK4 might not be the optimal concentration. Human keratinocytes, however, upregulated TSLP when stimulated with FSL-1, a TLR 2/6-L. 19 TLR-2 can form heterodimers with either TLR-1 or TLR-6, and it is possible that human keratinocytes form TLR-2/6 dimers whereas equine keratinocytes form TLR-1/2 dimers, and thus upregulate TSLP when stimulated with corresponding ligands. 13 Interestingly, conversely to humans, flagellin did not induce a strong upregulation of TSLP in equine keratinocytes; however, this TLR-L induced a strong TSLP production in equine PBMCs. How these TLR-L actually impact skin inflammation remains to be elucidated.
In order to investigate whether TLR-L-induced TSLP expression is indeed mediated via TLR signalling, the expression of the pro-inflammatory cytokine IL-6 induced via NF-jB, a downstream TLR signalling pathway effector, was examined.
18,23 IL-6 was upregulated as expected by stimulation with TLR 1-5-L, but not with TLR 7-L and 8-L, suggesting that resiquimod induced TSLP expression may not be mediated via TLR 7 and 8. Moreover, it is known that some ligands, such as dsRNA (TLR-3 ligand) also can be recognized by molecules other than TLR 3, such as melanoma differentiation antigen 5 (MDA5), retinoid-inducible gene 1 (RIG-1) and IFN-inducible double stranded RNA-activated protein kinase (PKR). [24] [25] [26] Therefore, further studies will be required to decipher the exact mechanisms of TLR-L-induced TSLP expression in primary equine keratinocytes.
The TLR-L-induced expression patterns of TSLP and IL-6 differed between equine keratinocytes and PBMCs. For example, the strongest TSLP upregulation in PBMCs was induced by flagellin, which induced only a moderate Statistical analysis of differences between groups was performed using the Mann Whitney U-test. *p ≤ 0.05 expression of this cytokine in keratinocytes. This indicates that certain cell types in PBMCs express a different set of TLRs when compared to keratinocytes and are therefore stimulated to produce TSLP. However, it is not known which cell types are sources of equine TSLP in PBMCs, and this needs further investigation. Moreover, patterns of TLR expression in equine PBMCs remain to be elucidated. In addition, the expression profile and activity of different TLRs in equine keratinocytes are currently unknown.
In allergic humans, TH-2 cytokines (IL-4, IL-13) and TNF-a have been described as atopic cytokine milieu. 19, 21, 22 Keratinocytes can come into contact with this milieu through interactions with TH-2 cells, basophils or mast cells that produce these cytokines. Therefore, to study the possible effect of atopic cytokine milieu alone or in combination with Pam3CSK4 or Poly (I:C) on TSLP expression, cytokines of atopic inflammatory milieu (recombinant equine IL-4 and TNF-a) were added to the culture medium. The milieu was combined only with Pam3CSK4 and Poly (I:C), the TLR-L that induced a clear TSLP upregulation in the present study. Addition of the atopic cytokine milieu alone already induced a significant TSLP upregulation, and when combined with Pam3CSK4 or Poly (I:C), it synergistically further upregulated TSLP expression. In skin allergic conditions including IBH, clinical signs are exacerbated by secondary bacterial infections. 10, 27 As mentioned, Pam3CSK4 is a constituent of bacterial membranes recognized by TLR1/2 heterodimers. 28 The results herein showing a strong upregulation of TSLP expression by Pam3CSK4 and its synergistic effects with atopic cytokine milieu, suggest that secondary bacterial infections in an allergic microenvironment can amplify TH-2 inflammation via the induction of TSLP, thus forming a vicious circle and exacerbation of the disease. Likewise, combining Poly (I:C) with the atopic cytokine milieu significantly increased TSLP gene expression after both 4 h and 24 h stimulation, when compared to Poly (I:C)-induced TSLP expression. Interestingly, dsRNA and Poly (I:C) TLR-3 have been associated with the mechanism for detection of skin damage and early inflammation initiation independent of viral activation. 29 Because IBH lesions have evident skin damage that in chronic cases can occur as epidermal necrosis, it is speculated that dsRNA released from damaged cells can trigger TSLP production in keratinocytes and could thus result in exacerbation of the disease. These synergistic effects of the atopic cytokine milieu and TLR-L on TSLP expression also have been described in human: TLR-L Poly (I:C), FSL-1 and flagellin-induced TSLP expression, and, additionally, when combined with allergic inflammation cytokine milieu, these TLR-L synergistically further upregulate TSLP expression. 19, 21, 22 Based on the data herein, it is therefore hypothesized that stimulation of TLR on keratinocytes by bacterial or viral PAMPs from the environment may lead to an increased release of TSLP in horses suffering from IgE-mediated skin allergies. This effect may be due to the allergic cytokine microenvironment in the skin of these animals, as demonstrated for IBH and recurrent urticaria. 17, 30 Further studies to investigate TSLP expression at the protein level are now required to confirm the role of TSLP in equine skin allergy.
In conclusion, the present study strongly suggests an important role for TSLP in the pathogenesis of IBH, as demonstrated by increased mRNA expression in the skin of IBH-affected horses as well as by the strong ability of equine keratinocytes to produce TSLP in response to TLR-L, present in the skin microenvironment and possibly also in the saliva of the causative insects. Further studies will be needed to elucidate whether the response of keratinocytes differs solely between allergic and nonallergic horses, or whether the observed increased TSLP expression is only associated with the allergic inflammation micro-milieu present in the skin of IBH-affected horses. Table S1b . Median IL-6 mRNA expression (presented as Log 2 DDCT) in keratinocytes stimulated with PMA-Ionomycin as positive control and various Toll like receptorLigands in comparison to non-stimulated cells for 4 and 24 hours. Table S1c . Effect of a combination of IL-4 and TNF-a on TSLP expression. Table S1d . Effect of a combination of IL-4 and TNF-a on IL-6 expression. Resumen Introducci on -la linfopoyetina del estroma t ımico (TSLP) desempeña un papel clave en el desarrollo de la inflamaci on al ergica. Poco se sabe sobre posibles desencadenantes de expresi on de TSLP equina. Hip otesis/objetivos -investigar la expresi on de TSLP en lesiones cut aneas de hipersensibilidad por picadura de insecto en equinos (IBH). Se examinaron la capacidad de los ligandos TLR 1-8 (L) y del medio de citoquinas en atopia como posibles desencadenantes de TSLP y de interleuquina (IL) -6 como una mol ecula efectora posterior a la señal estimulante de TLR en cultivos primarios de queratinocitos equinos. Animales -se tomaron muestras de piel lesionada de caballos con IBH y de piel sana de caballos control (n = 9 cada grupo). M etodos y materiales -se establecieron cultivos de queratinocitos a partir de seis caballos sanos y se estimularon con TLR 1-8-L, y con IL-4 y factor de necrosis tumoral-a, para imitar un medio de citoquinas en inflamaci on en atopia. La expresi on del gen TSLP e IL-6 se evaluaron por PCR cuantitativa en tiempo real. Resultados -la expresi on de TSLP fue significativamente mayor en los queratinocitos de lesiones de IBH en comparaci on con los de la piel sana. TLR 1-8-L aument o significativamente la expresi on de TSLP en queratinocitos. La regulaci on positiva m as fuerte fue inducida por TLR 1/2-L y TLR 3-L. La combinaci on del medio de citoquinas en atopia y TLR 1/2-L o TLR 3-L aument o a un m as la expresi on de TSLP. La estimulaci on de TLRL 1-5 aument o significativamente la expresi on de IL-6. Conclusiones e importancia cl ınica -los datos en este documento sugieren que la regulaci on positiva de la expresi on de TSLP en la piel lesionada de los caballos afectados por IBH podr ıa desempeñar un papel en el desarrollo de IBH. Adem as, la expresi on de TSLP es inducida por TLR-L, en particular por TLR 1/2-L y TLR 3-L, y aumenta a un m as por medio de citoquinas en atopia, lo que indica un mecanismo para la exacerbaci on de signos cl ınicos de IBH mediada por TSLP. 
Resumo
Contexto -A linfopoietina estromal t ımica (TSLP) desempenha um papel fundamental no desenvolvimento da inflamac ßão al ergica. Pouco se sabe sobre poss ıveis gatilhos da expressão de TSLP em equinos. Hip otese/objetivos -Investigar a expressão de TSLP em lesões cutâneas de hipersensibilidade a picada de inseto (IBH) em equinos. A capacidade dos ligantes TLR 1-8 (L) e do meio de citocinas at opicas como potenciais gatilhos da TSLP e da interleucina (IL) -6 como uma mol ecula efetora a jusante da sinalizac ßão de TLR, foram examinados em culturas prim arias de queratin ocitos equinos. Animais -Coletou-se a amostras de pele lesional de equinos afetados por IBH e a pele saud avel de cavalos controle (n = 9 cada grupo). M etodos e materiais -Culturas de queratin ocitos foram iniciadas a partir de material de seis equinos saud aveis e estimuladas com TLR 1-8-L, IL-4 e com fator de necrose tumoral-a, para imitar um meio de citocina de inflamac ßão at opica. A expressão do gene TSLP e IL-6 foi avaliada por PCR quantitativo em tempo real. Resultados -A expressão de TSLP foi significativamente maior nas lesões de IBH em comparac ßão com a pele saud avel. TLR 1-8-L aumentou positivamente a expressão de TSLP nos queratin ocitos. Maior regulac ßão positiva foi induzida por TLR 1/2-L e TLR 3-L. A combinac ßão do meio de citocinas at opicas e TLR 1/2-L ou TLR 3-L aumentou ainda mais a expressão de TSLP. A estimulac ßão com TLRL 1-5 aumentou significativamente a expressão de IL-6. Conclusões e importância cl ınica -Os dados do presente estudo sugerem que a regulac ßão positiva da expressão de TSLP na pele lesional de cavalos afetados por IBH pode desempenhar um papel no desenvolvimento da IBH. Al em disso, a expressão de TSLP e induzida por TLR-L, em particular por TLR 1/2-L e TLR 3-L, e e ainda aumentada pelo meio de citocinas at opicas, indicando um mecanismo para a exacerbac ßão da IBH mediada por TSLP.
